A case of ceftriaxone-induced immune haemolytic anaemia in an ambulatory care setting
Background: Drug-induced immune haemolytic anaemia (DIIHA) is a rare adverse effect which varies between mild to fatal (Garratty, 2010). One of the most common class of drugs reported to cause severe DIIHA are the second and third generation cephalosporins (e.g. ceftriaxone) (Garratty, 2010; Hill et...
Main Authors: | Rakhee Mistry, Luke S.P. Moore, Nabeela Mughal, Andrew Godfrey, Stephen Hughes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Clinical Infection in Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590170224000013 |
Similar Items
-
Distinct lipid profile in haemolytic anaemia-related gallstones compared with the general gallstone
by: Ziqi Wan, et al.
Published: (2023-12-01) -
Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis
by: Paul R.J. Ames, et al.
Published: (2020-06-01) -
Treatment of Autoimmune Haemolytic Anaemia with Hepatitis C Virus-A Real Challenge
by: A Basu, et al.
Published: (2016-10-01) -
Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy
by: Beatriz Fernández-Rubio, et al.
Published: (2023-02-01) -
Furosemide‐induced haemolytic anaemia in an extreme elderly patient
by: I‐Wei Ho, et al.
Published: (2023-04-01)